School of Medicine, University of Wollongong, New South Wales.
Community Pharmacist, New South Wales.
Aust N Z J Public Health. 2017 Apr;41(2):210-214. doi: 10.1111/1753-6405.12589. Epub 2016 Oct 24.
To investigate consumers' knowledge about commonly purchased over-the-counter (OTC) products containing ibuprofen.
Customers buying two popular OTC ibuprofen-containing products (Nurofen or Nurofen Plus ) were asked to complete a short survey assessing their knowledge about the products.
The survey was completed by 262 respondents, most of whom were older than 50 years of age; female; well-educated; with adequate functional health literacy. The majority correctly identified ibuprofen as an active ingredient and knew the correct intervals between doses. However, almost a third couldn't correctly identify the maximum daily dose and were unaware of some contraindications. Furthermore, fewer than half recognised potential side effects. Those who hadn't completed high school were significantly less likely to seek medical advice (when required) and significantly less likely to know when it was safe to take these products.
The gaps in consumer knowledge, especially about the maximum daily dose, contraindications and potential side effects may be placing consumers at risk of experiencing ibuprofen-related adverse events. Implications for public health: Improving consumer knowledge to address these gaps in their understanding about the safe use of popular OTC ibuprofen-containing products is an important public health concern.
调查消费者对常见的非处方(OTC)含布洛芬产品的了解程度。
询问购买两种广受欢迎的 OTC 布洛芬产品(Nurofen 或 Nurofen Plus)的顾客完成一项简短调查,评估他们对产品的了解程度。
共有 262 名受访者完成了调查,他们大多数年龄在 50 岁以上;女性;受教育程度较高;具有足够的功能性健康素养。大多数人正确识别出布洛芬是一种活性成分,并且知道正确的剂量间隔。然而,近三分之一的人无法正确识别最大日剂量,并且不知道一些禁忌症。此外,不到一半的人认识到潜在的副作用。那些没有完成高中学业的人明显不太可能(在需要时)寻求医疗建议,并且不太可能知道何时可以安全使用这些产品。
消费者知识的差距,尤其是关于最大日剂量、禁忌症和潜在副作用的知识,可能使消费者面临布洛芬相关不良事件的风险。对公共卫生的影响:提高消费者的知识水平,以解决他们在安全使用广受欢迎的 OTC 含布洛芬产品方面理解上的这些差距,是一个重要的公共卫生问题。